Guinea-Bissau Suspends US Vaccine Study Amid Claims of Cancellation
A highly contentious vaccine study in the West African nation of Guinea-Bissau has been put on hold after claims emerged that it had been cancelled due to concerns over ethics. The study, which aimed to investigate the health effects of giving hepatitis B vaccines alongside other shots to infants, was initially approved by Guinea-Bissau's ethics committee and was slated to involve 7,000 children.
However, in a shocking twist, the country's newly appointed minister of health, Quinhin Nantote, revealed that the trial had been "suspended" due to scientific inadequacy. Nantote stated that the science behind the study was not well-reviewed, sparking outrage from African health leaders and experts.
"This is not acceptable," said Dr. Abdulhammad Babatunde, a medical doctor and global health researcher in Nigeria. "To prevent things like the Tuskegee study and others, the control group has to get the standard of care, and the intervention group should get [potentially] better care."
The decision to halt the trial has been met with skepticism by officials from international organizations, including the US Department of Health and Human Services (HHS). HHS spokesperson Andrew Nixon claimed that the Africa CDC was "waging a public-relations campaign aimed to shape public perception rather than engaging with the scientific facts".
However, Jean Kaseya, director-general of the Africa CDC, refuted these claims, stating that "it's the sovereignty of the country" and emphasizing that decisions regarding research should be made by local authorities.
Critics argue that the study was never adequately reviewed, particularly given its design which involved withholding vaccines from some newborns. The World Health Organization recommends giving the hepatitis B vaccine to all newborns within 24 hours of birth.
The controversy highlights the challenges faced by Guinea-Bissau in addressing health issues, including limited access to basic services such as water and sanitation, poverty, and food insecurity. Experts stress that decisions about research must be made with caution, taking into account local context and concerns about ethics.
A highly contentious vaccine study in the West African nation of Guinea-Bissau has been put on hold after claims emerged that it had been cancelled due to concerns over ethics. The study, which aimed to investigate the health effects of giving hepatitis B vaccines alongside other shots to infants, was initially approved by Guinea-Bissau's ethics committee and was slated to involve 7,000 children.
However, in a shocking twist, the country's newly appointed minister of health, Quinhin Nantote, revealed that the trial had been "suspended" due to scientific inadequacy. Nantote stated that the science behind the study was not well-reviewed, sparking outrage from African health leaders and experts.
"This is not acceptable," said Dr. Abdulhammad Babatunde, a medical doctor and global health researcher in Nigeria. "To prevent things like the Tuskegee study and others, the control group has to get the standard of care, and the intervention group should get [potentially] better care."
The decision to halt the trial has been met with skepticism by officials from international organizations, including the US Department of Health and Human Services (HHS). HHS spokesperson Andrew Nixon claimed that the Africa CDC was "waging a public-relations campaign aimed to shape public perception rather than engaging with the scientific facts".
However, Jean Kaseya, director-general of the Africa CDC, refuted these claims, stating that "it's the sovereignty of the country" and emphasizing that decisions regarding research should be made by local authorities.
Critics argue that the study was never adequately reviewed, particularly given its design which involved withholding vaccines from some newborns. The World Health Organization recommends giving the hepatitis B vaccine to all newborns within 24 hours of birth.
The controversy highlights the challenges faced by Guinea-Bissau in addressing health issues, including limited access to basic services such as water and sanitation, poverty, and food insecurity. Experts stress that decisions about research must be made with caution, taking into account local context and concerns about ethics.